BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33031216
Number of visits today
3985
Number of downloads
16219873
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Yuan P, Song J, Wang F, Zhu G, Chen B. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma. Invest New Drugs 2022;40:1125-32. [PMID: 35793038 DOI: 10.1007/s10637-022-01257-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo P, Pi X, Gao F, Li Q, Li D, Feng W, Cao W. Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study. Front Oncol 2022;12:945915. [DOI: 10.3389/fonc.2022.945915] [Reference Citation Analysis]
2 Marcus R, Christopher W, Keller J, Nassoiy S, Chang SC, Goldfarb M, Wolf R, Jutric Z. Systemic Therapy Is Associated with Improved Oncologic Outcomes in Resectable Stage II/III Intrahepatic Cholangiocarcinoma: An Examination of the National Cancer Database over the Past Decade. Cancers (Basel) 2022;14:4320. [PMID: 36077855 DOI: 10.3390/cancers14174320] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345